Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gemma Caterina Maria Rossi

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Medicine|August 13, 2024
Editorial: Women in science: ophthalmology 2023Menaka C Thounaojam, Gemma Caterina Maria Rossi
Journal of Glaucoma|June 5, 2003
The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliabilityGemma Caterina Maria Rossi, Giovanni Milano, Carmine Tinelli
Frontiers in Aging Neuroscience|June 2, 2022
Editorial: Glaucoma and Brain: Impact of Neurodegeneration on Visual Abilities and Related BiomarkersTeresa Rolle, Gemma Caterina Maria Rossi, Paolo Brusini
Nutrients|December 28, 2021
A Pilot, Phase II, Observational, Case-Control, 1-Month Study on Asthenopia in Video Terminal Operators without Dry Eye: Contrast Sensitivity and Quality of Life before and after the Oral Consumption of a Fixed Combination of Zinc, L-Carnitine, Extract of Elderberry, Currant and Extract of EleutherococcusGemma Caterina Maria Rossi, Luigia Scudeller, Federica Bettio, et al.
Frontiers in Neurology|September 6, 2021
Editorial: Neuroinflammation and the Visual SystemGemma Caterina Maria Rossi, Claudia Angela Michela Gandini Wheeler-Kingshott, Ahmed Toosy
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 11, 2012
Ocular surface disease and glaucoma: how to evaluate impact on quality of lifeGemma Caterina Maria Rossi, Gian Maria Pasinetti, Luigia Scudeller, et al.
Expert Opinion on Pharmacotherapy|June 18, 2011
From dorzolamide 2%/timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month, multicenter, open-label tolerability switch studyGemma Caterina Maria Rossi, Gian Maria Pasinetti, Francesco Sandolo, et al.
International Ophthalmology|June 9, 2018
Prevalence of dry eye in video display terminal users: a cross-sectional Caucasian study in ItalyGemma Caterina Maria Rossi, Luigia Scudeller, Federica Bettio, et al.
European Journal of Ophthalmology|June 25, 2009
Dry eye syndrome-related quality of life in glaucoma patientsGemma Caterina Maria Rossi, Carmine Tinelli, Gian Maria Pasinetti, et al.
Expert Opinion on Drug Safety|March 12, 2015
From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerabilityGemma Caterina Maria Rossi, Luigia Scudeller, Teresa Rolle, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Medicine|August 13, 2024
Editorial: Women in science: ophthalmology 2023Menaka C Thounaojam, Gemma Caterina Maria Rossi
Journal of Glaucoma|June 5, 2003
The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliabilityGemma Caterina Maria Rossi, Giovanni Milano, Carmine Tinelli
Frontiers in Aging Neuroscience|June 2, 2022
Editorial: Glaucoma and Brain: Impact of Neurodegeneration on Visual Abilities and Related BiomarkersTeresa Rolle, Gemma Caterina Maria Rossi, Paolo Brusini
Nutrients|December 28, 2021
A Pilot, Phase II, Observational, Case-Control, 1-Month Study on Asthenopia in Video Terminal Operators without Dry Eye: Contrast Sensitivity and Quality of Life before and after the Oral Consumption of a Fixed Combination of Zinc, L-Carnitine, Extract of Elderberry, Currant and Extract of EleutherococcusGemma Caterina Maria Rossi, Luigia Scudeller, Federica Bettio, et al.
Frontiers in Neurology|September 6, 2021
Editorial: Neuroinflammation and the Visual SystemGemma Caterina Maria Rossi, Claudia Angela Michela Gandini Wheeler-Kingshott, Ahmed Toosy
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 11, 2012
Ocular surface disease and glaucoma: how to evaluate impact on quality of lifeGemma Caterina Maria Rossi, Gian Maria Pasinetti, Luigia Scudeller, et al.
Expert Opinion on Pharmacotherapy|June 18, 2011
From dorzolamide 2%/timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month, multicenter, open-label tolerability switch studyGemma Caterina Maria Rossi, Gian Maria Pasinetti, Francesco Sandolo, et al.
International Ophthalmology|June 9, 2018
Prevalence of dry eye in video display terminal users: a cross-sectional Caucasian study in ItalyGemma Caterina Maria Rossi, Luigia Scudeller, Federica Bettio, et al.
European Journal of Ophthalmology|June 25, 2009
Dry eye syndrome-related quality of life in glaucoma patientsGemma Caterina Maria Rossi, Carmine Tinelli, Gian Maria Pasinetti, et al.
Expert Opinion on Drug Safety|March 12, 2015
From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerabilityGemma Caterina Maria Rossi, Luigia Scudeller, Teresa Rolle, et al.
Pageof 3